Literature DB >> 21445825

Prognosis in patients with non-small cell lung cancer and satellite tumors.

C I Kocaturk1, M Z Gunluoglu, L Cansever, I S Dincer, M A Bedirhan.   

Abstract

BACKGROUND: Aim of the study was to identify factors affecting survival in patients with lung cancer and satellite tumors (ST).
METHODS: Between 2001 and 2008, there were 102 patients with synchronous multiple lung cancers among the 1355 lung resections performed in lung cancer patients. Satellite tumors were found to be near the primary lung cancer (PLC) in 29 patients.
RESULTS: Complete resection was achieved in all patients, and the 5-year survival rate was 52 %. The independent "T" stages of the PLCs and STs did not affect survival ( P = 0.98 and P = 0.54, respectively). A distance between the PLC and ST longer or shorter than 2, 3, or 4 cm also did not affect survival ( P = 0.78, P = 0.57, and P = 0.62, respectively). The survival of patients treated with adjuvant therapy was significantly higher than that of patients who did not receive adjuvant therapy ( P = 0.0043).
CONCLUSIONS: Satisfactory survival was achieved after surgical therapy for non-small cell lung cancer associated with ST. While the PLC and ST characteristics and the distance between tumors did not affect survival rates, the introduction of adjuvant chemotherapy with/without radiotherapy positively affected survival. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21445825     DOI: 10.1055/s-0030-1270799

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer?

Authors:  Nigar Dirican; Ahmet Dirican; Orhan Sen; Ayse Aynali; Sule Atalay; Haci Ahmet Bircan; Onder Oztürk; Serpil Erdogan; Munire Cakir; Ahmet Akkaya
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

2.  OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC.

Authors:  Yanzhang Hao; Jianwei Liu; Ping Wang; Feng Wang; Zeshun Yu; Mianli Li; Shaoshui Chen; Fangling Ning
Journal:  Int J Genomics       Date:  2014-08-05       Impact factor: 2.326

3.  SUVmax and Tumor Size Predict Surgical Outcome of Synchronous Multiple Primary Lung Cancers.

Authors:  Hsian-He Hsu; Kai-Hsiung Ko; Yu-Ching Chou; Lin-Fan Lin; Wen-Chuan Tsai; Shih-Chun Lee; Hung Chang; Tsai-Wang Huang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.